New aspects in the pathogenesis of miscarriage in women with extragenital pathology
Keywords:miscarriage, pregravid period, gestation period, matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, diseases of the hepatobiliary system, hepatic steatosis, non-alcoholic steatohepatitis
Study objective: to determine the dynamics of type 9 metalloproteinase (MMP-9) and its tissue inhibitor-1 (TIMP-1) in the pathogenesis of early miscarriage in women with chronic diseases of the hepatobiliary system.
Materials and methods. The study included 39 women with a history of early pregnancy miscarriage, who were diagnosed with chronic liver diseases as a result of clinical, instrumental and laboratory studies (17 persons with steatosis and 22 persons with non-alcoholic steatohepatitis). The control group consisted of 8 women without somatic pathology and 8 pregnant women at the first trimester of gestation. MMP-9 and TIMP-1 value in the blood serum was determined by the enzyme immunoassay.
Results. MMP-9 and TIMP-1 growth in the blood serum of women with a history of miscarriage was established in the pre-gravidar period. The most significant increase in the parameters of the intercellular matrix was found in patients with non-alcoholic steatohepatitis. MMP-9 and TIMP-1 increased in in blood serum in the first trimester in women with liver diseases. MMP-9 increased against the background of a decrease in the TIMP-1 activity in patients with the threat of premature pregnancy termination. Miscarriage was diagnosed in patients with a minimum value of a tissue inhibitor.
Conclusions. There is an imbalance between MMP-9 and TIMP-1 in the blood serum in women with early miscarriage and chronic diseases of the hepatobiliary system. MMP-9 and TIMP-1 level in patients with hepatic steatosis is lower than in patients with non-alcoholic steatohepatitis. MMP-9 increased during physiological pregnancy, and the TIMP-1 activity practically did not change, which indicates the role of MMP-9 in the initial stages of placentation. MMP-9 value in women with a burdened premorbid background with a physiological course of pregnancy and threatening early spontaneous miscarriage was significantly different. The highest activity of MMP-9 was in women with the threat of spontaneous miscarriage in the early stages. TIMP-1 in the first trimester in women with chronic liver disease increased in those with a favorable course of pregnancy and decreased in the threat of spontaneous miscarriage. Such changes in MMP-9 and TIMP-1 in patients with miscarriage indicate the accumulation of intercellular matrix and sclerotic changes in the vessels that provide blood to the uterus.
- Batrak, N.V., Malyshkina, A.I., Sotnikova, N.Y., Kroshkina, N.V. Risk factors and immunological mechanisms of the threat of early pregnancy termination and habitual miscarriage. Monograph. Ivanovo (2020): 120 p.
- Belyaeva, M.A., Bobrov, S.A., Lapin, S.V. “Clinical and immunological interactions in the recurrent miscarriage and their correction methods (review).” Bulletin of the North-Western State Medical University named after I. I. Mechnikov 7.3 (2015): 118–23.
- Bobrov, S.A., Belyaeva, M.A. ”Immunological aspects of miscarriage.” International Scientific and Practical Conference World science 2.3.3 (2015): 18–21.
- Golyanovskyi, O.V., Zhuravliova, L.A., Savonik, A.O. “The course of pregnancy, childbirth and the postpartum period in women with diseases of the hepatobiliary system.” Perinatology and phthisiology 3.67 (2016): 23–7.
- Dovzhikova, I.V., Lutsenko, M.T. ”Modern concepts of progesterone role (review).” Bulletin of Respiratory Physiology and Pathology 60 (2016): 94–104.
- Ivanis, V.A., Putilova, E.A., Gorelova, I.S., et al. “Role of matrix metalloproteinase-9 in the diagnosis of liver fibrosis in patients with chronic mono-and mixed-viral hepatitis.” Pacific Medical Journal 4.50 (2012): 74–7.
- Karpeev, S.A., Grinevich, V.B., Karpeeva, Y.S., Balukova, E.V. “Assessment of the state of the hepatopancreatobiliary system in patients with habitual miscarriage.” Gastroenterology of St. Petersburg 1 (2017): 83–83a.
- Korenovskiy, Y.V., Sinelnikova, L.M., Filchakova, O.N., et al. “Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in pregnancy and childbirth.” Acta Biomedica Scientifica 5–2.87 (2012): 146–9.
- Marakhovskaya, T.A. “Matrix metalloproteinases: role in the pregnancy's pathology.” Valeology 3 (2017): 24–37.
- Milovanov, A.P., Rasstrigina, I.M., Fokina, T.V. “The role of metalloproteinase-2 and -9 in physiological and pathological pregnancy.” Clinical and experimental morphology 4 (2012): 70–4.
- Radzinskiy, V.E., Ordiyants, I.M., Pobedinskaya, O.S., Zykov, E.V. “Progesterone and reproductive losses.” Obstetrics and gynecology 8 (2017): 109–14.
- Sudakova, O.A., Frolov, M.V. “Analysis of the causes of miscarriage in urgent gynecology.” Scientific Medical Bulletin of the Central Chernozem Region 71 (2018): 149–53.
- Khvorostukhina, N.F., Stepanova, N.N., Novikov, D.A., Mamedova, G.E. “Features of hormonal homeostasis in miscarriage and preterm birth.” International Journal of Experimental Education 12–3 (2015): 445–6.
- Khobzey, M.K., Kharchenko, N.V., et al. Unified clinical protocol of primary, secondary (specialized) medical care: non-alcoholic steatohepatitis. Approved by the order of the MoH of Ukraine on November 06, 2014 No. 826. Kyiv (2014): 37 p.
- Alghamdi, S., Fleckenstein, J. “Liver Disease in Pregnancy and Transplant.” Curr Gastroenterol Rep 21.9 (2019): 43.
- Grzela, K., Litwiniuk, M., Zagorska, W., Grzela, T. “Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9.” Arch Immunol Ther Exp (Warsz) 64.1 (2016): 47–55.
- Lee, S.K., Na, B.J., Kim, J.Y., et al. “Determination of clinical cellular immune markers in women with recurrent pregnancy loss.” Am J Reprod Immunol 70.5 (2013): 398–411.
- Ma, K., Berger, D., Reau, N. “Liver Diseases During Pregnancy.” Clin Liver Dis 23.2 (2019): 345–61.
- Mikolasevic, I., Filipec-Kanizaj, T., Jakopcic, I., et al. “Liver Disease During Pregnancy: A Challenging Clinical Issue.” Med Sci Monit 24 (2018): 4080–90.
- Milić, S., Tatalović, T., Mikolašević, I. “Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation.” Best Pract Res Clin Gastroenterol (2020): 44–5.
- Odendaal, J., Quenby, S., Sammaritano, L., et al. “Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence?” Fertil Steril 112.6 (2019): 1002–12.
- Shekhar, S., Diddi, G. “Liver disease in pregnancy.” Taiwan J Obstet Gynecol 54.5 (2015): 475–82.
- Tran, T.T., Ahn, J., Reau, N.S. “ACG Clinical Guideline: Liver Disease and Pregnancy.” Am J Gastroenterol 111.2 (2016): 176–96.
- Westbrook, R.H., Dusheiko, G., Williamson, C. “Pregnancy and liver disease.” J Hepatol 64.4 (2016): 933–45.
- Zeng, Z., Lui, F., Li, S. “Metabolic Adaptation in Pregnancy: A Review.” Ann Nutr Metab 70.1 (2017): 59–65.
How to Cite
Copyright (c) 2021 І.В. Лоскутова, Р.Г. Бічевська, Н.Г. Корнієць
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.